Enabling in-house 2-hour COVID-19 batch testing*

Easily screen staff icon

Quickly screen patients, staff & essential workers

Easy to use

Easy to use and minimal training

Quickly Screen

One year warranty

Two hour tests

Run up to 6 COVID-19 2SF tests in about two hours

Two hour tests

Ships within two days

*Must be a CLIA-certified high-complexity laboratory as outlined under the FDA's Emergency Use Authorization requirements.
At this time, only serving the midwest states of Nebraska, Iowa, Kansas, South Dakota and North Dakota.



Keep Your Community Safe

Cassling is honored to partner with MatMaCorp, a Nebraska-based company, to provide an affordable solution to supplement the COVID-19 testing at your facility.

The Solas8® device, along with the MatMaCorp COVID-19 2SF Test, is designed for rapid detection of SARS-CoV-2 RNA for the diagnosis of COVID-19.

Questions? Call customer support at 402-387-7900.

Introducing the Solas8® Device

  • Run up to six tests at a time with positive results in as little as 90 minutes and negative results in about two hours
  • The device is small enough to fit in a space designed for a laptop
  • Easy-to-navigate instructions on the touch screen
  • Reagents are lyophilized for a long shelf life (no refrigeration)
  • Affordable pricing for the device and tests
  • Extraction, reaction and detection all performed on same device
  • No additional capital equipment, reagents or kits required



Key Product Features

  • Specifically detects SARS-CoV-2; no cross-reaction with other viral and bacterial pathogens
  • Easy RNA isolation in just 5 minutes
  • Sensitive to as little as 100 viral genomes per reaction
  • Requires sterile water, filtered pipette tips and adjustable pipette



Product Quantity Price
Solas8 Device 1 $9,500
MatMaCorp COVID-19 2SF Test 100 reactions $3,000


Place Your Order Today

Click the button below to be taken to our order form, then simply select the number of devices and testing kits you'd like to order.




Disclaimer: This test has not been FDA cleared or approved but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and The emergency use of this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.